Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_assertion description "[Transcriptome studies indeed revealed that pheochromocytomas and paragangliomas can be classified into two major clusters depending on their gene expression profile: Cluster 1 comprises samples associated with a hypoxic signature such as SDHx- and VHL-related tumors and cluster 2 includes RET, NF1, and TMEM127-mutated tumors, as well as most of sporadic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_assertion evidence source_evidence_literature NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_assertion SIO_000772 22183643 NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_assertion wasDerivedFrom befree-2016 NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_assertion wasGeneratedBy ECO_0000203 NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.
- befree-2016 importedOn "2016-02-19" NP947950.RAYwdoMgyw-HERmJUfAu2F3q5x0dtPSqO_Prk-idlaePA130_provenance.